In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BD Plays It Safe

Executive Summary

It's not often that a company gets the chance to, in effect, reinvent a major product category. Moreover, it's not often that government legislators and regulators give the company a significant boost in its effort. But that's exactly what's happened for sharps product leader Becton Dickinson & Co. As concerns about health care worker safety mount, legislation recently enacted in California requires hospitals to convert from severly price-squeezed conventional sharps products to new, specially-designed products--a kind of decommoditization of these highly commoditized product categories. And BD officials hope the California law is only the beginning.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV001231

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel